Effects of aminoglutethimide on plasma estrone sulfate not caused by aromatase inhibition.

[1]  P. Lønning,et al.  Alterations in the urine excretion of estrogen metabolites in breast cancer women treated with aminoglutethimide. , 1989, Journal of steroid biochemistry.

[2]  T. Thorsen,et al.  Alterations in the Metabolism of Oestrogens During Treatment with Aminoglutethimide in Breast Cancer Patients , 1987, Clinical pharmacokinetics.

[3]  M. Ghilchik,et al.  Estrogen production and metabolism in normal postmenopausal women and postmenopausal women with breast or endometrial cancer. , 1986, European journal of cancer & clinical oncology.

[4]  P. Goss,et al.  Pyridoglutethimide [3-ethyl-3-(4-pyridyl)-piperidine-2,6-dione], an analogue of aminoglutethimide. Metabolism and pharmacokinetics. , 1986, Biochemical pharmacology.

[5]  M. Dowsett,et al.  A comparison of the endocrine effects of low dose aminoglutethimide with and without hydrocortisone in postmenopausal breast cancer patients. , 1985, British Journal of Cancer.

[6]  M. Dowsett,et al.  ENDOCRINE EFFECTS OF LOW DOSE AMINOGLUTETHIMIDE AS AN AROMATASE INHIBITOR IN THE TREATMENT OF BREAST CANCER , 1985, Clinical endocrinology.

[7]  P. Lønning,et al.  Effect of aminoglutethimide on antipyrine, theophylline, and digitoxin disposition in breast cancer , 1984, Clinical pharmacology and therapeutics.

[8]  R. Santen,et al.  In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway. , 1984, The Journal of clinical endocrinology and metabolism.

[9]  G. Bolelli,et al.  Estrone sulphate plasma levels in postmenopausal women with and without endometrial cancer , 1984, Cancer.

[10]  M. Dowsett,et al.  Hydrocortisone alone vs hydrocortisone plus aminoglutethimide: a comparison of the endocrine effects in postmenopausal breast cancer. , 1984, European journal of cancer & clinical oncology.

[11]  O. Myking,et al.  Conjugated and unconjugated plasma oestrogens in men with chronic alcoholism and in normal men. , 1984, Journal of steroid biochemistry.

[12]  G. Adessi,et al.  Estrone and dehydroepiandrosterone sulfatase activities and plasma estrone sulfate levels in human breast carcinoma. , 1984, Cancer research.

[13]  R. Paridaens,et al.  EFFECTS OF AMINOGLUTETHIMIDE ON ADRENAL STEROID SECRETION , 1983, Clinical endocrinology.

[14]  M. Reed,et al.  Plasma levels of estrone, estrone sulfate, and estradiol and the percentage of unbound estradiol in postmenopausal women with and without breast disease. , 1983, Cancer research.

[15]  M. Dowsett,et al.  Endocrine effects of low dose aminoglutethimide alone in advanced postmenopausal breast cancer. , 1983, British Journal of Cancer.

[16]  M. Dowsett,et al.  Aminoglutethimide dose and hormone suppression in advanced breast cancer. , 1983, European journal of cancer & clinical oncology.

[17]  L. Lagasse,et al.  Origin of Serum Estradiol in Postmenopausal Women , 1982, Obstetrics and gynecology.

[18]  R. Santen,et al.  Plasma estrone-sulfate assessment of reduced estrogen production during treatment of metastatic breast carcinoma , 1982, Steroids.

[19]  H. Jacobs,et al.  The plasma concentration of oestrone sulphate in postmenopausal women: lack of diurnal variation, effect of ovariectomy, age and weight. , 1981, Journal of steroid biochemistry.

[20]  R. Santen,et al.  A randomized trial comparing surgical adrenalectomy with aminoglutethimide plus hydrocortisone in women with advanced breast cancer. , 1981, The New England journal of medicine.

[21]  J. Thijssen,et al.  Plasma oestrone, oestradiol and androstenedione levels in post-menopausal women: relation to body weight and height. , 1981, Maturitas.

[22]  T. Thorsen,et al.  Conjugated and unconjugated plasma oestrogens--oestrone, oestradiol and oestriol--in normal human males. , 1980, Journal of steroid biochemistry.

[23]  R. Santen,et al.  Preservation of androgen secretion during estrogen suppression with aminoglutethimide in the treatment of metastatic breast carcinoma. , 1980, The Journal of clinical investigation.

[24]  K. Roberts,et al.  Plasma estrone sulfate levels in postmenopausal women , 1980, Steroids.

[25]  C. Longcope,et al.  Estrone sulfate and dehydroepiandrosterone sulfate concentrations in normal subjects and men with cirrhosis , 1979, Steroids.

[26]  R. Santen,et al.  Aminoglutethimide inhibits extraglandular estrogen production in postmenopausal women with breast carcinoma. , 1978, The Journal of clinical endocrinology and metabolism.

[27]  M. Kirschner,et al.  Androgen-estrogen production rates in postmenopausal women with breast cancer. , 1978, Cancer research.

[28]  P. Siiteri,et al.  Effect of obesity on conversion of plasma androstenedione to estrone in postmenopausal women with and without endometrial cancer. , 1978, American journal of obstetrics and gynecology.

[29]  R. Santen,et al.  Adrenal suppression with aminoglutethimide. II. Differential effects of aminoglutethimide on plasma androstenedione and estrogen levels. , 1977, The Journal of clinical endocrinology and metabolism.

[30]  A. Vermeulen.  The hormonal activity of the postmenopausal ovary. , 1976, The Journal of clinical endocrinology and metabolism.

[31]  R. Santen,et al.  Successful medical adrenalectomy with amino-glutethimide. Role of altered drug metabolism. , 1974, JAMA.

[32]  J. Mikuta,et al.  Plasma estrogens in postmenopausal women. , 1973, American journal of obstetrics and gynecology.

[33]  P. Siiteri,et al.  Source of Estrogen Production in Postmenopausal Women , 1973 .

[34]  H. Ruder,et al.  Estrone sulfate: production rate and metabolism in man. , 1972, The Journal of clinical investigation.

[35]  R. Cash,et al.  Inhibition of Adrenal Steroidogenesis by Amino-Glutethimide and the Mechanism of Action , 1967 .

[36]  P. Satoh,et al.  Aminoglutethimide (Elipten-Ciba) as an inhibitor of adrenal steroidogenesis: mechanism of action and therapeutic trial. , 1967, The Journal of clinical endocrinology and metabolism.

[37]  C. Huggins,et al.  Bilateral adrenalectomy in the treatment of cancer of the breast. , 1955, A.M.A. archives of surgery.

[38]  P. Lønning,et al.  Treatment of breast carcinoma with aminoglutethimide. , 1984, Acta radiologica. Oncology.

[39]  R. Santen,et al.  Aminoglutethimide as treatment of postmenopausal women with advanced breast carcinoma. , 1982, Annals of internal medicine.

[40]  W. Lawrence,et al.  Medical adrenalectomy and plasma steroids in advanced breast carcinoma. , 1978, Surgery.